Description
Altretamine is an anticancer chemotherapeutic agent that binds DNA at guanine and cytosine residues, forming DNA adducts. This alkylating agent is also metabolized to formaldehyde. Altretamine is clinically used to treat ovarian cancer.
Product Unit Size | Cost | Quantity | Stock |
---|
Altretamine is an anticancer chemotherapeutic agent that binds DNA at guanine and cytosine residues, forming DNA adducts. This alkylating agent is also metabolized to formaldehyde. Altretamine is clinically used to treat ovarian cancer.
Cas No. | 645-05-6 |
---|---|
Purity | ≥98% |
Formula | C9H18N6 |
Formula Wt. | 210.28 |
Chemical Name | N,N,N',N',N'',N''-Hexamethyl-1,3,5-triazine-2,4,6-triamine |
IUPAC Name | 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine |
Synonym | HMM, Hexalen, Hexamethylmelamine |
Melting Point | 172-174°C |
Solubility | Practically insoluble in water. Soluble in DMSO. |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Chan JK, Loizzi V, Manetta A, et al. Oral altretamine used as salvage therapy in recurrent ovarian cancer. Gynecol Oncol. 2004 Jan;92(1):368-71. PMID: 14751188.
Coley HM, Brooks N, Phillips DH, et al. The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studies. Biochem Pharmacol. 1995 May 11;49(9):1203-12. PMID: 7763301.
Hansen LA, Hughes TE. Altretamine. DICP. 1991 Feb;25(2):146-52. PMID: 1905441.
Inhibitor of CDK.
Oxidized non-cylic hexose sugar.
ALK, c-Fes, LRRK2 inhibitor.
Synthetic derivative of vasicine, mucolytic.
GHB agonist, D2/3 antagonist.
Non-endogenous essential amino acid found in me...
CRTH2 inhibitor.
Phenol found in various plant sources, used to ...
NSAID; COX-1/2 inhibitor.
FAK inhibitor.
EGFR inhibitor.
N-acetyl cysteine conjugate of phenethylisothio...
Antifungal antibiotic
5-HT1A agonist, 5-HT2A antagonist.
Cytarabine derivative, nucleoside (cytosine) an...
Endogenous cardiomodulatory peptide; NPR-A agon...
Azapirone; α1-adrenergic and 5-HT1A partial ag...
SHP2 inhibitor
Cannabinoid receptor 2 selective agonist.
Derivative of camptothecin.